Medical Communications
FDA refuses to regulate CBD, calling on Congress to take charge
January 27, 2023 Medical Communications
The FDA is calling on the US Congress to work with them on a new regulatory pathway for cannabidiol (CBD). …
FDA pulls approval of COVID-19 antibody treatment due to inefficacy against variants
January 27, 2023 Medical Communications
The FDA has revoked its approval of AstraZeneca’s Evusheld due to the fact that it is not effective against more …
iNtRON confirms efficacy of ‘Inhalation Anthrax’-fighting drug
January 26, 2023 Medical Communications
iNtRON, a bio-new drug developing venture company, has announced the completion of an efficacy evaluation study of BAL200. It has …
Cell BioEngines announces exclusive licencing agreement for cancer cure
January 26, 2023 Medical Communications
US-based cell and gene therapy company Cell BioEngines has announced its exclusive licencing agreement with Icahn School of Medicine at …
Bristol Myers Squibb sues AstraZeneca over alleged patent infringement of cancer drug
January 25, 2023 Medical Communications
Bristol Myers Squibb (BMS) has filed a lawsuit against AstraZeneca, alleging that AstraZeneca’s Imjudo infringes patents from its blockbuster drug …
Thermo Fisher Scientific announces launch of CE-IVD marked assay to detect treatment-resistant strains of HIV-1
January 25, 2023 Medical Communications
US-based Thermo Fisher Scientific has announced the launch of its CE-IVD marked Applied Biosystems Taqpath Seq HIV-1 Genotyping kit. It …
Europe plans further antibiotic shortage countermeasures
January 24, 2023 Medical Communications
With respiratory infections increasing, an ongoing cost of living crisis and the Russia-Ukraine conflict, officials throughout Europe are beginning to …
WHO issues a “call to action” after cough syrup deaths
January 24, 2023 Medical Communications
WHO has released an urgent “call to action” to all 194 WHO member states in order to try and prevent, …
First Indian intranasal COVID-19 vaccine about to launch
January 23, 2023 Medical Communications
Indian biotech company Bharat Biotech plans to launch its new intranasal COVID-19 vaccine iNCOVACC on the 26 January 2023 ‒ …
FDA awards CardioRenal Systems Breakthrough Device Designation for RenalGuard Therapy
January 23, 2023 Medical Communications
The FDA has granted Breakthrough Device Designation for US-based medical technology company CardioRenal for their RenalGuard Therapy device, used to …
Merck attempts to reduce levels of carcinogenic compounds in diabetes drugs
January 20, 2023 Medical Communications
Pharmaceutical company Merck has announced that it is attempting to reduce levels of a cancer-causing compound which has been found …
Alnylam and PTC Therapeutics’ rare disease drugs given backing by NICE
January 20, 2023 Medical Communications
Alnylam’s Amvuttra and PTC Therapeutics’ Translarna will be available to patients through the NHS after being backed by NICE, despite …
Abbott secures FDA approval for Navitor TAVI device
January 19, 2023 Medical Communications
US-based medical device firm Abbott has secured FDA approval for Navitor to treat people with aortic stenosis who are at …
Johnson & Johnson cuts trial for its HIV vaccine following disappointing data
January 19, 2023 Medical Communications
Johnson & Johnson (J&J) has announced that it has ended its clinical trial for its experimental HIV vaccine, following disappointing …
AI tool to improve blood sugar management in type 1 diabetes patients
January 18, 2023 Medical Communications
A new app, designed by researchers at Oregon Health & Science University (OSHU), uses artificial intelligence (AI) to assess blood …
Latest content
October 26, 2026
